{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T18:44:50Z","timestamp":1764873890630,"version":"3.37.3"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:00:00Z","timestamp":1632873600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:00:00Z","timestamp":1632873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Life expectancy has greatly increased, generating an improvement in screening programs for disease prevention, lifesaving drugs and medical devices. The impact of lowering low-density lipoprotein cholesterol (LDL-C) in the very elderly is not well-established. Our aim was to explore the association of LDL-C, high density lipoprotein cholesterol (HDL-C) and lipid lowering drugs (LLDs) on cognitive decline, malignancies and overall survival.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This was a retrospective cohort study. Our study comprised 1498 (72.7%) males and 561 (27.3%) females, aged \u226570 who had attended the Institute for Medical Screening\u00a0(IMS), Sheba Medical Center, Israel at least twice during 2013\u20132019. Data were obtained from the computerized database of the IMS. A manual quality control to identify potential discrepancies was performed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Overall, 6.3% of the subjects treated with LLDs (95\/1421) versus 4.2% not treated (28\/638), cognitively declined during the study years. No statistically significant effects of LDL-C, HDL-C and LLDs on cognitive decline were observed after correcting for age, prior stroke and other vascular risk factors. With regard to cancer, after adjusting for confounders and multiple inferences, no definite relationships were found.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This analysis of an elderly, high socioeconomic status cohort suggests several relationships between the use of LLDs and health outcomes, some beneficial, especially, with regard to certain types of cancer, but with a higher risk of cognitive decline. Further studies are warranted to clarify the health effects of these medications in the elderly.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12944-021-01529-2","type":"journal-article","created":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T10:14:06Z","timestamp":1632910446000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["An impact of lipid profile and lipid lowering drugs on \u226570\u2009year olds of an upper socioeconomic class: a retrospective cohort study"],"prefix":"10.1186","volume":"20","author":[{"given":"Yehudit","family":"Eden Friedman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Canetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ido","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shlomo","family":"Segev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6068-0675","authenticated-orcid":false,"given":"Ophira","family":"Salomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,29]]},"reference":[{"issue":"11","key":"1529_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11883-017-0683-9","volume":"19","author":"M Leya","year":"2017","unstructured":"Leya M, Stone NJ. Statin prescribing in the elderly: special considerations. Curr Atheroscler Rep. 2017;19(11):47. https:\/\/doi.org\/10.1007\/s11883-017-0683-9.","journal-title":"Curr Atheroscler Rep"},{"issue":"10170","key":"1529_CR2","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0140-6736(18)31942-1","volume":"393","author":"Cholesterol Treatment Trialists\u2019 Collaboration","year":"2019","unstructured":"Cholesterol Treatment Trialists\u2019 Collaboration. Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials. Lancet. 2019;393(10170):407\u201315. https:\/\/doi.org\/10.1016\/S0140-6736(18)31942-1.","journal-title":"Lancet."},{"issue":"20","key":"1529_CR3","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1161\/CIRCULATIONAHA.117.028271","volume":"135","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Lonn E, Paynter NP, Glynn R, Yusuf S. Primary prevention with statin therapy in the elderly: new meta-analyses from the contemporary JUPITER and HOPE-3 randomized trials. Circulation. 2017;135(20):1979\u201381. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.028271.","journal-title":"Circulation."},{"issue":"6","key":"1529_CR4","doi-asserted-by":"publisher","first-page":"e010401","DOI":"10.1136\/bmjopen-2015-010401","volume":"6","author":"U Ravnskov","year":"2016","unstructured":"Ravnskov U, Diamond DM, Hama R, Hamazaki T, Hammarskjold B, Hynes N, et al. Lack of an association or an inverse association between low density lipoprotein cholesterol and mortality in the elderly: a systemic review. BMJ Open. 2016;6(6):e010401. https:\/\/doi.org\/10.1136\/bmjopen-2015-010401.","journal-title":"BMJ Open"},{"issue":"1","key":"1529_CR5","first-page":"3","volume":"39","author":"U Ravnskov","year":"2009","unstructured":"Ravnskov U, McCully KS. Vulnerable plaque formation from obstruction of vasa vasorum by homocysteinylated and oxidized lipoprotein aggregates complexed with microbial remnants and LDL autoantibodies. Ann Clin Lab Sci. 2009;39(1):3\u201316.","journal-title":"Ann Clin Lab Sci"},{"issue":"3","key":"1529_CR6","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1161\/01.cir.86.3.1046","volume":"86","author":"D Jacobs","year":"1992","unstructured":"Jacobs D, Blackburn H, Higgins M, Reed D, Iso H, McMillan G, et al. Report of the conference on low blood cholesterol: mortality associations. Circulation. 1992;86(3):1046\u201360. https:\/\/doi.org\/10.1161\/01.cir.86.3.1046.","journal-title":"Circulation."},{"issue":"1","key":"1529_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1161\/01.cir.79.1.8","volume":"79","author":"DJ Gordon","year":"1989","unstructured":"Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 1989;79(1):8\u201315. https:\/\/doi.org\/10.1161\/01.cir.79.1.8.","journal-title":"Circulation."},{"issue":"4","key":"1529_CR8","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.jacl.2017.05.004","volume":"11","author":"X Lin","year":"2017","unstructured":"Lin X, Lu L, Liu L, Wei S, He Y, Change J, et al. Blood lipids profile and lung cancer risk in a meta-analysis of prospective cohort studies. J Clin Lipidol. 2017;11(4):1073\u201381. https:\/\/doi.org\/10.1016\/j.jacl.2017.05.004.","journal-title":"J Clin Lipidol"},{"issue":"2","key":"1529_CR9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10654-014-9884-5","volume":"29","author":"M His","year":"2014","unstructured":"His M, Zelek L, Deschasaux M, Pouchieu C, Kesse-Guyot E, Hercberg S, et al. Prospective associations between serum biomarkers of lipid metabolism and overall , breast and prostate cancer risk. Eur J Epidemiol. 2014;29(2):119\u201332. https:\/\/doi.org\/10.1007\/s10654-014-9884-5.","journal-title":"Eur J Epidemiol"},{"issue":"3","key":"1529_CR10","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1017\/S000711451500183X","volume":"114","author":"M Touvier","year":"2015","unstructured":"Touvier M, Fassier P, His M, Norat T, Chan DSM, Blacher J, et al. Cholesterol and breast cancer risk: a systematic review and meta-analysis of prospective studies. Br J Nutr. 2015;114(3):347\u201357. https:\/\/doi.org\/10.1017\/S000711451500183X.","journal-title":"Br J Nutr"},{"issue":"11","key":"1529_CR11","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1158\/1940-6207","volume":"4","author":"K Aleksandrova","year":"2011","unstructured":"Aleksandrova K, Boeing H, Jenab M, Bas Bueno-de-Mesquita H, Jansen E, van Duijnhovern FJB, et al. Metabolic syndrome and risk of colon and rectal cancer: the European prospective investigation into cancer and nutrition study. Cancer Prev Res. 2011;4(11):1873\u201383. https:\/\/doi.org\/10.1158\/1940-6207.","journal-title":"Cancer Prev Res"},{"key":"1529_CR12","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.cca.2017.11.039","volume":"477","author":"P Zhou","year":"2018","unstructured":"Zhou P, Li B, Liu B, Chen T, Xiao J. Prognostic role of serum total cholesterol and high-density lipoprotein cholesterol in cancer survivors. A systemic review and meta-analysis. Clin Chim Acta. 2018;477:94\u2013104. https:\/\/doi.org\/10.1016\/j.cca.2017.11.039.","journal-title":"Clin Chim Acta"},{"key":"1529_CR13","doi-asserted-by":"publisher","first-page":"792034","DOI":"10.1155\/2012\/792034","volume":"2012","author":"W Wulaningsih","year":"2012","unstructured":"Wulaningsih W, Garmo H, Holmberg L, Hammer N, Jungner I, Wallidius G, et al. Serum lipids and the risk of gastrointestinal malignancies in the Swedish AMORIS study. J Cancer Epidemiol. 2012;2012:792034. https:\/\/doi.org\/10.1155\/2012\/792034.","journal-title":"J Cancer Epidemiol"},{"issue":"8","key":"1529_CR14","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s40266-015-0290-9","volume":"32","author":"M Teng","year":"2015","unstructured":"Teng M, Lin L, Zhao YJ, Leng Khoo A, Davis BR, Wei Yong Q, et al. Statins for primary prevention of cardiovascular disease in elderly patients: systematic review and meta-analysis. Drugs Aging. 2015;32(8):649\u201361. https:\/\/doi.org\/10.1007\/s40266-015-0290-9.","journal-title":"Drugs Aging"},{"issue":"3","key":"1529_CR15","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/s11606-014-3115-3","volume":"30","author":"BR Ott","year":"2015","unstructured":"Ott BR, Daiello LA, Dahabreh IJ, Springate BA, Bixby K, Murali M, et al. Do statins impair cognition? A systematic review and meta-analysis of randomized controlled trials. J Gen Intern Med. 2015;30(3):348\u201358. https:\/\/doi.org\/10.1007\/s11606-014-3115-3.","journal-title":"J Gen Intern Med"},{"issue":"2","key":"1529_CR16","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s11011-018-0373-5","volume":"34","author":"C Stough","year":"2019","unstructured":"Stough C, Pipingas A, Camfield D, Nolidin K, Savage K, Deleil S, et al. Increases in total cholesterol and low density lipoprotein associated with decreased cognitive performance in healthy elderly adults. Metab Brain Dis. 2019;34(2):477\u201384. https:\/\/doi.org\/10.1007\/s11011-018-0373-5.","journal-title":"Metab Brain Dis"},{"issue":"1","key":"1529_CR17","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13024-017-0167-y","volume":"12","author":"C Ma","year":"2017","unstructured":"Ma C, Yin Z, Zhu P, Luo J, Shi X, Gao X. Blood cholesterol in late-life and cognitive decline: a longitudinal study of the Chinese elderly. Mol Neurodegener. 2017;12(1):24. https:\/\/doi.org\/10.1186\/s13024-017-0167-y.","journal-title":"Mol Neurodegener"},{"issue":"9716","key":"1529_CR18","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","volume":"375","author":"N Sattar","year":"2010","unstructured":"Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen ANJM, et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet. 2010;375(9716):735\u201342. https:\/\/doi.org\/10.1016\/S0140-6736(09)61965-6.","journal-title":"Lancet."},{"issue":"3","key":"1529_CR19","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1053\/j.gastro.2012.06.001","volume":"143","author":"DA Lieberman","year":"2012","unstructured":"Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US multi-society task force on colorectal Cancer. Gastroenterology. 2012;143(3):844\u201357. https:\/\/doi.org\/10.1053\/j.gastro.2012.06.001.","journal-title":"Gastroenterology."},{"key":"1529_CR20","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/NEJMoa1102873","volume":"365","author":"NLSTR Team","year":"2011","unstructured":"Team NLSTR, Aberle DR, Adams AM, et al. Reduced lung cancer mortality with low dose computed tomographic screening. N Eng J Med. 2011;365:395\u2013409. https:\/\/doi.org\/10.1056\/NEJMoa1102873.","journal-title":"N Eng J Med"},{"key":"1529_CR21","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2307\/2346101","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. JRStatist Soc B. 1995;57:289\u2013300. https:\/\/doi.org\/10.2307\/2346101.","journal-title":"JRStatist Soc B"},{"key":"1529_CR22","unstructured":"Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. National institutes of health. Obes Res. 1998;6:51S\u2013209S."},{"issue":"10","key":"1529_CR23","doi-asserted-by":"publisher","first-page":"5250","DOI":"10.1073\/pnas.1915884117","volume":"117","author":"JM Aburto","year":"2020","unstructured":"Aburto JM, Villavicencio F, Basellini U, Kjaegaard S, Vaupel JW. Dynamics of life expectancy and life span equality. Proc Natl Acad Sci U S A. 2020;117(10):5250\u20139. https:\/\/doi.org\/10.1073\/pnas.1915884117.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1529_CR24","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.mayocp.2018.10.005","volume":"94","author":"RJ Pignolo","year":"2019","unstructured":"Pignolo RJ. Exceptional human longevity. Mayo Clin Proc. 2019;94(1):110\u201324. https:\/\/doi.org\/10.1016\/j.mayocp.2018.10.005.","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"1529_CR25","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1093\/ije\/dym079","volume":"36","author":"DE Bloom","year":"2007","unstructured":"Bloom DE, Canning D. Commentary: the Preston curve 30 years on: still sparking fires. Int J Epidemiol. 2007;36(3):498\u20139. https:\/\/doi.org\/10.1093\/ije\/dym079.","journal-title":"Int J Epidemiol"},{"issue":"4","key":"1529_CR26","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1365-2796.2010.02331.x","volume":"269","author":"L Wilhelmsen","year":"2011","unstructured":"Wilhelmsen L, Sv\u00e4rdsudd K, Eriksson H, Rosengren A, Hansson P-O, Welin C, et al. Factors associated with reaching 90 years of age: a study of men born in 1913 in Gothenburg, Sweden. J Intern Med. 2011;269(4):441\u201351. https:\/\/doi.org\/10.1111\/j.1365-2796.2010.02331.x.","journal-title":"J Intern Med"},{"issue":"11","key":"1529_CR27","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.3390\/ijerph16112028","volume":"16","author":"T Brenn","year":"2019","unstructured":"Brenn T. Survival to age 90 in men: the Troms\u00f8 study 1974-2018. Int J Environ Res Public Health. 2019;16(11):2028. https:\/\/doi.org\/10.3390\/ijerph16112028.","journal-title":"Int J Environ Res Public Health"},{"key":"1529_CR28","unstructured":"Israel National Health Interview Survey INHIS-3, 2013\u20132015\u2013Selected Findings. Israel Center for Disease Control, Ministry of Health Publication. 2017:374. https:\/\/www.health.gov.il\/publicationsfiles\/inhis_3.pdf."},{"key":"1529_CR29","doi-asserted-by":"publisher","unstructured":"Mahlknecht U, Kaiser S. Age-related changes in peripheral blood counts in humans. Exp Ther Med. 2010;1(6):1019\u201325. https:\/\/doi.org\/10.3892\/etm.2010.150.","DOI":"10.3892\/etm.2010.150"},{"issue":"5","key":"1529_CR30","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1212\/WNL.0b013e318227b227","volume":"77","author":"S Debette","year":"2011","unstructured":"Debette S, Seshadri S, Beiser A, Au R, Himali JJ, Palumbo C, et al. Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology. 2011;77(5):461\u20138. https:\/\/doi.org\/10.1212\/WNL.0b013e318227b227.","journal-title":"Neurology."},{"issue":"3","key":"1529_CR31","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s12603-016-0701-6","volume":"20","author":"YB Lv","year":"2016","unstructured":"Lv YB, Yin ZX, Chei C-L, Brasher MS, Zhang J, Kraus VB, et al. Serum cholesterol levels within the high normal range are associated with better cognitive performance among Chinese elderly. J Nutr Health Aging. 2016;20(3):280\u20137. https:\/\/doi.org\/10.1007\/s12603-016-0701-6.","journal-title":"J Nutr Health Aging"},{"issue":"1","key":"1529_CR32","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3233\/JAD-121138","volume":"34","author":"Y Katsumata","year":"2013","unstructured":"Katsumata Y, Todoriki H, Higashiuesato Y, Yasura S, Ohya Y, Willcox C, et al. Very old adults with better memory function have higher low-density lipoprotein cholesterol levels and lower triglyceride to high-density lipoprotein cholesterol ratios: KOCOA project. J Alzheimers Dis. 2013;34(1):273\u20139. https:\/\/doi.org\/10.3233\/JAD-121138.","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"1529_CR33","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1038\/s41591-019-0597-x","volume":"25","author":"BA Dickerman","year":"2019","unstructured":"Dickerman BA, Garc\u00eda-Alb\u00e9niz X, Logan RW, Denaxas S, Hernan MA. Avoidable flaws in observational analyses: an application to statins and cancer. Nature Med. 2019;25(10):1601\u20136. https:\/\/doi.org\/10.1038\/s41591-019-0597-x.","journal-title":"Nature Med"},{"issue":"11","key":"1529_CR34","doi-asserted-by":"publisher","first-page":"5569","DOI":"10.1158\/0008-5472.CAN-07-0212","volume":"67","author":"U Lim","year":"2007","unstructured":"Lim U, Gayles T, Katki HA, Stolzenberg-Solomon R, Weinstein SJ, Pietinen P, et al. Serum high-density lipoprotein cholesterol and risk of non-Hodgkin lymphoma. Cancer Res. 2007;67(11):5569\u201374. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-0212.","journal-title":"Cancer Res"},{"issue":"2","key":"1529_CR35","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/jgs.16306","volume":"68","author":"AX Maihofer","year":"2020","unstructured":"Maihofer AX, Shadyab AH, Wild RA, LaCroix AZ. Associations between serum levels and cholesterol and survival to age 90 in postmenopausal women. J Am Geriatr Soc. 2020;68(2):288\u201396. https:\/\/doi.org\/10.1111\/jgs.16306.","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"1529_CR36","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2459\/JCM.0000000000000611","volume":"19","author":"F Gragnano","year":"2018","unstructured":"Gragnano F, Natale F, Concilio C, Fimiani F, Cesaro A, Sperlongano S, et al. Adherence to proprotein convertase subtilisin\/kexin 9 inhibitors in high cardiovascular risk patients: an Italian single-center experience. J Cardiovasc Med. 2018;19(2):75\u20137. https:\/\/doi.org\/10.2459\/JCM.0000000000000611.","journal-title":"J Cardiovasc Med"},{"issue":"7","key":"1529_CR37","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1056\/NEJMoa1701131","volume":"377","author":"RP Giugliano","year":"2017","unstructured":"Giugliano RP, Mach F, Zavitz K, Kurtz C, Im K, Kanevsky E, et al. Cognitive function in a randomized trial of Evolocumab. N Engl J Med. 2017;377(7):633\u201343. https:\/\/doi.org\/10.1056\/NEJMoa1701131.","journal-title":"N Engl J Med"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-021-01529-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-021-01529-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-021-01529-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T10:15:24Z","timestamp":1632910524000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-021-01529-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,29]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1529"],"URL":"https:\/\/doi.org\/10.1186\/s12944-021-01529-2","relation":{},"ISSN":["1476-511X"],"issn-type":[{"type":"electronic","value":"1476-511X"}],"subject":[],"published":{"date-parts":[[2021,9,29]]},"assertion":[{"value":"28 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board of the SMC, Israel approved the study (registered as #6327\u201319-SMC). A waiver of consent was obtained from the IRB.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"120"}}